Javascript required
Skip to content Skip to sidebar Skip to footer

Wicked Witch of the West by Cameron Blakey by Cameronblakeyart on Deviantart Art Drawing

Adjunct membership is for researchers employed by other institutions who collaborate with IDM Members to the extent that some of their own staff and/or postgraduate students may piece of work within the IDM; for three-year terms, which are renewable.


BARRY Three, Dr Clifton
PhD, Section Chief and Senior Investigator, Tuberculosis Enquiry Section (TRS), National Institute of Allergy and Infectious Diseases (NIAID) at the United states National Institutes of Health (NIH).

Areas of interest span the basic sciences of chemical science, biochemistry and microbiology, through to pharmacology and clinical medicine, in the areas of mycobacterial pathogenesis and TB drug discovery research.

email


BROWN, Prof Gordon
PhD, FRS, FMedSci, FRSB, FAAM, FRSE, RSSAf, Director MRC Center for Medical Mycology at the University of Exeter and Managing director of the AFGrica Unit of measurement at The University of Cape Town (UCT). Honorary Professor at UCT.

His primary enquiry interests are C-type lectin receptors and their role in homeostasis and immunity, with a item focus on antifungal immunity.

email


GRAY, Prof Clive
Professor Emeritus of Immunology, Sectionalisation of Immunology, Department of Pathology, University of Cape Town; Professor of Immunology in Molecular Biological science and Human Genetics, Stellenbosch University, Greatcoat Town; Adjunct Professor, Department of Immunology, Duke Academy, North Carolina, USA; Secretarial assistant-Full general, Federation of African Immunology Societies; Vice-Chair, Education Commission of the IUIS; Managing director of the Immunopaedia Foundation.

His research interests circumduct effectually investigating immune regulation and dysregulation in the context of HIV infection or exposure. He focuses on Allowed ontogenesis in HIV exposed infants, placental investigations and pre-term nascency, and epithelial immunity in the foreskin. He has an agile group within the IDM and is based at Stellenbosch University where he directs the Reproductive Immunology Inquiry Consortium in Africa (RIRCA). He is the by Chair of Immunology at UCT and holder of several NIH and European-based grants.

email


GRAY, Prof Glenda
MBBCH, FCP (Paeds) SA. Executive Director Perinatal HIV Research Unit, Wits Wellness Consortium, Academy of Witwatersrand; Associate Professor, Section of Paediatrics, University of Witwatersrand, South Africa; HVTN Managing director of International Programmes; HVTN Co-Principal Investigator; Chair of the standing committee on Wellness, ASSAF.

Her Enquiry Unit is involved with clinical enquiry, epidemiology and operational research, and is a treatment site for HIV infected adults and children. Her research interests include HIV vaccine enquiry, microbicide enquiry and other biomedical and behavioural interventions, and she is an investigator in testing two HIV vaccine regimens in tardily stage clinical development. Her TB inquiry includes examining new agents to foreclose TB, TB prophylaxis and TB vaccine evaluation.

email


GROBUSCH, Prof Martin
Professor, Dr. Med. (Thou.D.), PhD, Grand.Sc. (Lond), DTM&H (Lond), FRCP (Lond). Specialist in Internal Medicine, Infectious Diseases, Tropical Medicine. Full Professor and Chair of Tropical Medicine and Travel Medicine and Head, Heart of Tropical Medicine and Travel Medicine, Amsterdam Medical Centre, University of Amsterdam in kingdom of the netherlands.

He has been an author on over 150 manuscripts in the field of infectious diseases and has an extensive runway record in infectious diseases research and do covering clinical, laboratory and epidemiological aspects.

email


LESLIE, Dr Al
Principal investigator Africa Wellness Research Institute (AHRI), Durban, South Africa; Associate Professor, University of KwaZulu Natal, Durban, Southward Africa; Wellcome Trust senior Beau, department of infection and amnesty, University College London, Britain.

He is an HIV and TB immunologist focused on studying the immune response to these pathogens in affected tissues, and how this relates to what can be observed from the blood. The research goal is to improve agreement of the immunopathology of TB and HIV, using this information to aid in developing novel therapeutic approaches and diagnostic biomarkers.

email


LEWINSOHN , Prof Dave

MD, PhD, Professor and Vice Chair for Research, Department of Medicine, Manager OHSU Heart for Global Child Health Research, Department of Pediatrics.

His research has centered on agreement the mechanisms by which the man immune arrangement recognises the Mycobacterium tuberculosis (M.tb) infected cell. This research has focused largely on CD8+ T cells, with a focus on both those antigens that are recognised, and the means past which they are presented. His work has a strong translational component, asking if both classically and non-classically restricted T cells are associated with infection with Thousand. tb, reflect immunological retentiveness, and are enriched at the site of infection.

email


LEWINSOHN, Prof Deborah

MD, Professor, and Vice Chair for Inquiry, Segmentation Head Infectious disease, Wayne L. Tracy Professor of Infectious disease, Section of Pediatrics, Assistant Director, OHSU Centre for Global Child Wellness Research.

Her research focuses on agreement the role of the developing allowed organisation on the susceptibility of immature children to tuberculosis (TB) and understanding the part of innate and adaptively acquired CD8+ T cells in host defence force to TB. The translational significance of this inquiry is centred on informing the development of novel vaccines and diagnostics for childhood TB.

email


MOORE, A/Prof Penny
S African Enquiry Chair in Viral Host Dynamics, Faculty of Health Sciences, Academy of Witwatersrand and National Institute for Communicable diseases.

Her current research focuses on HIV broadly neutralising antibodies and their interplay with the evolving virus. Recent studies published in PloS Pathogens, Nature and Nature Medicine have highlighted the part of viral escape in creating new epitopes and immunotypes, thereby driving the development of neutralisation latitude, with implications for HIV vaccine design.

email


NICOL, Prof Marking
Schoolhouse of Biomedical Sciences, Division of Infection and Immunity, University of Western Australia; Professor in Microbiology.

Research interest in tuberculosis and in developing and testing signal of intendance diagnostics suitable for the developing globe.

email


REDD, Dr Andrew
PhD, Staff Scientist in International HIV and STD Section, National Institute of Allergy and Infectious Diseases at the The states National Institutes of Health; Assistant Professor of Medicine at Johns Hopkins University.

His research is focused on better understanding HIV transmission and disease dynamics with a special concentration on HIV superinfection, latent HIV infection, and the role of the virus in HIV+ organ transplantation.

email


WILKINSON, A/Prof Katalin
Main Inquiry Scientist at The Francis Crick Constitute London; Honorary Acquaintance Professor, Division of Infection and Amnesty, University College London; Honorary Associate Professor, Section of Medicine, University of Cape Town.

Her research focuses on the immunology of HIV-associated tuberculosis (TB). More specifically, the reconstitution of the immune response during antiretroviral treatment, in guild to identify correlates of protection (including immune mechanisms that lead to reduced susceptibility to TB), and pathogenesis (such equally the Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, TB-IRIS); the biosignature of the TB infection spectrum, from latent infection to agile illness; preventing TB infection in HIV infected people more effectively; and the pathogenesis of tuberculous meningitis and pericarditis.

email

frederickwhisis.blogspot.com

Source: http://www.idm.uct.ac.za/Adjunct_Members